Cargando…

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2

We previously reported CD63-BCAR4 fusion as a novel oncogene that significantly enhanced cell migration and metastasis in lung cancer. To identify effective inhibitors of metastatic activity induced by BCAR4 fusion, we screened a drug library of 381 FDA-approved compounds. The effect of drugs on cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Kieun, Kim, Jin Hee, Lee, Ja Young, Kong, Sun-Young, Kim, Yun-Hee, Kim, Sunshin, Yoon, Kyong-Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445485/ https://www.ncbi.nlm.nih.gov/pubmed/36081848 http://dx.doi.org/10.3389/fmolb.2022.952651

Ejemplares similares

A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis
por: Bae, Kieun, et al.
Publicado: (2020)

Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma
por: Yoon, Daseul, et al.
Publicado: (2019)

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2
por: Kim, Hwang-Phill, et al.
Publicado: (2009)

The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
por: Yuan, Meiqin, et al.
Publicado: (2022)

AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma
por: Fan, Dengxia, et al.
Publicado: (2023)

Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis
por: Zheng, Chang, et al.
Publicado: (2020)

Recombinant Prolidase Activates EGFR-Dependent Cell Growth in an Experimental Model of Inflammation in HaCaT Keratinocytes. Implication for Wound Healing
por: Nizioł, Magdalena, et al.
Publicado: (2022)

Uncovering the Mechanism of Drug Resistance Caused by the T790M Mutation in EGFR Kinase From Absolute Binding Free Energy Calculations
por: Zhou, Huaxin, et al.
Publicado: (2022)

Curcumin-mediated transcriptional regulation of human N-acetylgalactosamine-α2,6-sialyltransferase which synthesizes sialyl-Tn antigen in HCT116 human colon cancer cells
por: An, So-Young, et al.
Publicado: (2022)

Trimethyl-Chitosan Coated Gold Nanoparticles Enhance Delivery, Cellular Uptake and Gene Silencing Effect of EGFR-siRNA in Breast Cancer Cells
por: Baghani, Leila, et al.
Publicado: (2022)

Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma
por: Yoshikawa, D, et al.
Publicado: (2008)

ΔCT Value of Amplified Refractory Mutation System Predicts Efficacy of EGFR-TKIs in Advanced Non–Small-Cell Lung Cancer: A Multi-Center Retrospective Study
por: Chen, Min, et al.
Publicado: (2021)

High-Intensity Aerobic Exercise Suppresses Cancer Growth by Regulating Skeletal Muscle-Derived Oncogenes and Tumor Suppressors
por: Jee, Hyunseok, et al.
Publicado: (2022)

Molecular imaging of HER2 receptor: Targeting HER2 for imaging and therapy in nuclear medicine
por: Miladinova, Daniela
Publicado: (2023)

Interrelated Oncogenic Viruses and Breast Cancer
por: Afzal, Samia, et al.
Publicado: (2022)

Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
por: Kong, Gyeyeong, et al.
Publicado: (2020)

Corrigendum: Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
por: Kong, Gyeyeong, et al.
Publicado: (2021)

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

The Oncogenic Roles of JC Virus T Antigen in Breast Carcinogenesis
por: Zheng, Hua-chuan, et al.
Publicado: (2021)

An In Vivo C. elegans Model System for Screening EGFR-Inhibiting Anti-Cancer Drugs
por: Bae, Young-Ki, et al.
Publicado: (2012)

A perspective on the role of physiological stresses in cancer, diabetes and cognitive disease as environmental diseases
por: Esterhuizen, Maranda, et al.
Publicado: (2023)

The Mutational Landscape of the Oncogenic MZF1 SCAN Domain in Cancer
por: Nygaard, Mads, et al.
Publicado: (2016)

ST6Gal1: Oncogenic signaling pathways and targets
por: GC, Sajina, et al.
Publicado: (2022)

EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
por: Jo, Ukhyun, et al.
Publicado: (2014)

Editorial: Cancer Treatment and Early Detection Targeting HER Receptors
por: Cai, Xiaoqing, et al.
Publicado: (2022)

Specificity Assessment of CRISPR Genome Editing of Oncogenic EGFR Point Mutation with Single-Base Differences
por: Bae, Taegeun, et al.
Publicado: (2019)

SYDE1 Acts as an Oncogene in Glioma and has Diagnostic and Prognostic Values
por: Han, Zhenyuan, et al.
Publicado: (2021)

The oncogenic role of SNRPB in human tumors: A pan-cancer analysis
por: Wu, Juan, et al.
Publicado: (2022)

Characterization of Integrin Molecular Tension of Human Breast Cancer Cells on Anisotropic Nanopatterns
por: Kim, Kyung Ah, et al.
Publicado: (2022)

Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53
por: Marques, Mayra A., et al.
Publicado: (2022)

Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells
por: Yoon, Daseul, et al.
Publicado: (2018)

Cellular heterogeneity and plasticity during NAFLD progression
por: Park, Hyun-Ju, et al.
Publicado: (2023)

Editorial: Cancer treatment and early detection targeting HER receptors, Volume II
por: Cai, Xiaoqing, et al.
Publicado: (2023)

KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas
por: Kim, Jeong-Oh, et al.
Publicado: (2015)

Comprehensive Analysis Reveals USP45 as a Novel Putative Oncogene in Pan-Cancer
por: Li, Kai, et al.
Publicado: (2022)

Regulation of cellular contractile force, shape and migration of fibroblasts by oncogenes and Histone deacetylase 6
por: López-Guajardo, Ana, et al.
Publicado: (2023)

Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
por: Chen, Dong, et al.
Publicado: (2021)

Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification
por: Tanizaki, J, et al.
Publicado: (2011)

SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer
por: Wei, Zhengmao, et al.
Publicado: (2022)

Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
por: Sajjadi, Elham, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_93ui59940c6veg2iugi77kkbtd